NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
5 hedge funds and large institutions have $114K invested in Northwest Biotherapeutics, Inc. Common stock in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
MSAM
1
Moloney Securities Asset Management
Manchester,
Missouri
|
$38K |
| 2 |
OCG
2
Opus Capital Group
Cincinnati,
Ohio
|
$19K |
| 3 |
3
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
$3K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WJWM
1
Williams Jones Wealth Management
New York
| $39K | 50,000 | – | – |
|
|
MSAM
2
Moloney Securities Asset Management
Manchester,
Missouri
| $38K | 49,400 | +17,400 | +54% |
|
|
OCG
3
Opus Capital Group
Cincinnati,
Ohio
| $19K | 25,000 | +15,000 | +150% |
|
|
LDB
4
Lee, Danner & Bass
Nashville,
Tennessee
| $15K | 20,000 | – | – |
|
|
5
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $3K | 4,662 | +2,500 | +116% |
|